Economic evaluations of interventions to prevent healthcare-associated infections – literature review
Each year around 3.2 million patients are infected with healthcare-associated infections following exposure in healthcare facilities across the European Union and a total of 37 000 of them die as a direct consequence. Healthcare-associated infections are therefore of considerable concern to patients, healthcare professionals and policy-makers alike.
The aim of this review is to assist decision-makers by identifying and summarising existing economic evaluations and cost-effectiveness analyses associated with the control and/or prevention of healthcare-associated infections and to establish general assumptions which would be desirable for a common framework to enable future cost-effectiveness analyses in European hospital settings.
Laboratory manual for carbapenem and colistin resistance detection and characterisation for the survey of carbapenem- and/or colistin-resistant Enterobacteriaceae
18 Feb 2019 - This protocol is based partly on the laboratory manual developed for the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE)
Point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals - ECDC PPS validation protocol version 3.1.2.
10 Jan 2019 - This protocol version is an accompanying document to the ECDC protocol for the point prevalence survey of healthcare-associated infections and antimicrobial use in European acute care hospitals version 5.3.